Journal article icon

Journal article

Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance

Abstract:
We investigated the impact of breakpoint discrepancies between CLSI and EUCAST on susceptibility interpretation of clinical isolates at the Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos and performed a literature search to compare our findings to published reports. Zone diameters for first-line antimicrobial agents tested against non-duplicate clinical isolates of Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa in 2017 were interpreted separately using EUCAST 2018 and CLSI 2018 breakpoints and greement measured. Applying EUCAST instead of CLSI breakpoints to 428 E. coli, 208 K. pneumoniae and 78 P. aeruginosa isolates would have increased rates of ciprofloxacin resistance (59.1% vs 46.5% in E. coli, 37.5% vs 13.9% in K. pneumoniae, 28.2% vs 10.3% in P. aeruginosa) and amoxicillinclavulanic acid resistance (52.3% vs 19.9% in E. coli, 35.6% vs 22.1% in K. pneumoniae). Our results are supported by a literature search which identified 20 articles whose main objective was comparing susceptibility interpretation between CLSI and EUCAST. 19/20 articles reported significant discrepancies in one or more pathogen-antimicrobial combinations, nearly always due to a reduction in susceptibility rates and/or increase in resistance rates when applying more restrictive EUCAST breakpoints. We conclude that breakpoint discrepancies between CLSI and EUCAST have a significant impact on susceptibility interpretation of clinical isolates and AMR surveillance initiatives, and highlight the need for globally harmonized clinical breakpoints.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/j.cmi.2019.03.007

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Tropical Medicine
Role:
Author
ORCID:
0000-0002-7620-4822


Publisher:
Elsevier
Journal:
Clinical Microbiology and Infection More from this journal
Volume:
25
Issue:
7
Pages:
910-911
Publication date:
2019-03-22
Acceptance date:
2019-03-10
DOI:
EISSN:
1469-0691
ISSN:
1198-743X
Pmid:
30910717


Language:
English
Keywords:
Pubs id:
pubs:987008
UUID:
uuid:fe336545-aa71-408d-8179-c7e31bac7288
Local pid:
pubs:987008
Source identifiers:
987008
Deposit date:
2019-04-23

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP